| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Jan―23 |
Coronial reported alcohol-related mortality in Australia: pre-Covid-19 vs Covid-19 time periods |
Katarina Needham, Neil Langlois |
| 2 |
[GO] |
2024―May―06 |
Increase in invasive Haemophilus influenzae serotype A infections during the COVID-19 pandemic in New South Wales, Australia |
Winkie Fong, Elena Martinez, Verlaine Timms, Andrew Ginn, Trang Nguyen, Hossinur Rahman, Vitali Sintchenko |
| 3 |
[GO] |
2024―Apr―24 |
Continued improvement in the development of the SARS-CoV-2 whole genome sequencing proficiency testing program |
Katherine A. Lau, Charles S.P. Foster, Torsten Theis, Jenny Draper, Mitchell J. Sullivan, Susan Ballard, William D. Rawlinson |
| 4 |
[GO] |
2024―Apr―06 |
Trends in SARS-CoV-2 cycle threshold (Ct) values from nucleic acid testing predict the trajectory of COVID-19 waves |
Vishal Ahuja, Thomas Bowe, Gayle Warnock, Catherine Pitman, Dominic E. Dwyer |
| 5 |
[GO] |
2024―Mar―26 |
Dermatopathic lymphadenopathy after COVID-19 vaccination |
Jie-Yang Jhuang, Yen-Chieh Chen, Yung-Fang Chia, Shih-Sung Chuang |
| 6 |
[GO] |
2024―Jan―27 |
Irregular and out-of-season re-emergence of respiratory pathogens after lifting of COVID-19 pandemic response measures, Singapore |
Matthias Maiwald, Han Yang Soong, Wei Yee Wan, Liat Hui Loo |
| 7 |
[GO] |
2023―Oct―18 |
Fatal heart arrhythmia associated with enterovirus cardiac infection and SARS-CoV-2-induced cytokine storm |
Domitille Callon, Yohan N’Guyen, Paul Fornes, Laurent Andreoletti |
| 8 |
[GO] |
2023―Oct―12 |
Experience with COVID-19: swab technique shows no association with willingness to retest |
Haley Ruiz, Victoria Westley-Wise, Darren J. Mayne, Caitlin Keighley, Peter Newton, Spiros Miyakis, Holly Seale |
| 9 |
[GO] |
2023―Sep―01 |
SARS-CoV-2 infection of the placenta is associated with extensive fibrin deposition which may cause adverse pregnancy outcomes |
Stuart T. Hamilton, Christine Loo, Martin A. Weber, Roshini John, Antonia Shand, William D. Rawlinson |
| 10 |
[GO] |
2023―Aug―26 |
Vertical transmission of SARS-CoV-2 from mother to fetus |
Cosmin I. Mohor, George C. Oprinca, Alexandra Oprinca-Muja, Sorin R. Fleacă, Adrian Boicean, Ioana Boeraș, Mihai D. Roman, Călin I. Mohor |
| 11 |
[GO] |
2023―Aug―19 |
A case of COVID-19 mRNA vaccine-related erythema nodosum and interstitial granulomatous drug reaction |
Mingjuan Tan, Jamie J.M. Phua, Kuttiparambil Unnikrishnan, Kong Bing Tan, Chris Li Xian Tan |
| 12 |
[GO] |
2023―Jul―28 |
Cytomegalovirus and Aspergillus co-infection in an immunocompetent patient with severe COVID-19 |
Adina Dessauer, Daniel Hussey, Sadid F. Khan, Catriona A. McLean, Bradley J. Gardiner |
| 13 |
[GO] |
2023―Apr―09 |
Performance evaluation of Roche and Abbott Panbio multiplex SARS-CoV-2 and influenza A/B rapid antigen tests |
Mitchell Batty, Charlene Mackenzie, Joshua Deerain, Thomas Tran, Yano Yoga, Julian Druce, Deborah A. Williamson, Maryza Graham |
| 14 |
[GO] |
2023―Jan―27 |
Maternal COVID-19 infection and subacute placental histopathology |
Bruce Tsz Chun Chau, Jin Sung Byun, Leonardo Santos, Patricia Symons |
| 15 |
[GO] |
2023―Jan―27 |
Evaluating vitamin D levels during the NSW 2020 COVID-19 lockdown |
S. Clayton, B. Graham, K. Fildes, S. Min, C. Keighley |
| 16 |
[GO] |
2022―Aug―06 |
Analysis of SARS-CoV-2 real-time PCR test CT values across a population may afford useful information to assist public health efforts and add refinement to epidemiological models |
Robert Stevens, Ryan Pratama, Zin Naing, Anna Condylios |
| 17 |
[GO] |
2022―Aug―06 |
Severe autoimmune haemolytic anaemia following SARS-CoV-2 vaccination in patients with treatment naïve B-cell neoplasms: a case series |
Joshua Haron Abasszade, Paul Bao Duy La, Emily Shelmerdine, Anastasios Nalpantidis, Natasha Curtin, George Grigoriadis, Pasquale Luke Fedele |
| 18 |
[GO] |
2022―Jul―02 |
Cadaveric donor specimens and serological testing for SARS-CoV-2 |
Malinna Yeang, Vidiya Ramachandran, Zin Naing, Chee Choy Kok, William D. Rawlinson |
| 19 |
[GO] |
2022―Jun―29 |
Factors associated with weak positive SARS-CoV-2 diagnosis by reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) |
Priyank Rawat, Jennifer M. Zerbato, Ajantha Rhodes, Chris Chiu, Thomas Tran, Thomas A. Rasmussen, Julian Druce, Sharon R. Lewin, Michael Roche |
| 20 |
[GO] |
2022―Jun―29 |
Proficiency testing for SARS-CoV-2 whole genome sequencing |
Katherine A. Lau, Kristy Horan, Anders Gonçalves da Silva, Alexa Kaufer, Torsten Theis, Susan A. Ballard, William D. Rawlinson |
| 21 |
[GO] |
2022―Jun―09 |
Neuropathological findings in fatal COVID-19 and their associated neurological clinical manifestations |
Ignacio Ruz-Caracuel, Héctor Pian-Arias, Íñigo Corral, Irene Carretero-Barrio, Diego Bueno-Sacristán, Belén Pérez-Mies, Mónica García-Cosío, Tamara Caniego-Casas, David Pizarro, María Isabel García-Narros, Miguel Piris-Villaespesa, David Pestaña, Raúl de Pablo, Juan Carlos Galán, Jaime Masjuan, José Palacios |
| 22 |
[GO] |
2022―May―28 |
Pathology utilisation during COVID-19 outbreaks beyond viral testing: routine coagulation and D-dimer testing |
Emmanuel J. Favaloro, Michelle Lay, Soma Mohammed, Ronny Vong, Leonardo Pasalic |
| 23 |
[GO] |
2022―May―23 |
Local genomic sequencing enhances COVID-19 surveillance in the Northern Territory of Australia |
Ella M. Meumann, Dimitrios Menouhos, Stefanos Christofis, Kwaku M. Kondambu-Saaka, Jaimee Harbidge, Farshid Dakh, Kevin Freeman, Robert Baird |
| 24 |
[GO] |
2022―Apr―21 |
Evaluation of the influenza and respiratory syncytial virus (RSV) targets in the AusDiagnostics SARS-CoV-2, Influenza and RSV 8-well assay: sample pooling increases testing throughput |
Thuy Phan, Ngoc Yen Kim Tran, Thomas Gottlieb, Steven Siarakas, Genevieve McKew |
| 25 |
[GO] |
2022―Apr―16 |
SARS-CoV-2 N-gene mutation leading to Xpert Xpress SARS-CoV-2 assay instability |
Charles S.P. Foster, Mathew Madden, Raymond Chan, David Agapiou, Rowena A. Bull, William D. Rawlinson, Sebastiaan J. Van Hal |
| 26 |
[GO] |
2022―Apr―16 |
SARS-CoV-2 IgM testing for travellers: a private pathology perspective from New South Wales and the Australian Capital Territory, Australia |
Michael C. Wehrhahn, Gretschen Millan, James P. Newcombe, Matthew Long, Caitlin Keighley, Paul Whiting, Ian Chambers |
| 27 |
[GO] |
2022―Apr―16 |
Proficiency testing for SARS-CoV-2 in assuring the quality and overall performance in viral RNA detection in clinical and public health laboratories |
Katherine A. Lau, Alexa Kaufer, Joanna Gray, Torsten Theis, William D. Rawlinson |
| 28 |
[GO] |
2022―Feb―10 |
Clinical associations of SARS-CoV-2 viral load using the first WHO International Standard for SARS-CoV-2 RNA |
Peter Boan, Andrew Jardine, Todd M. Pryce |
| 29 |
[GO] |
2022―Feb―03 |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody kinetics after BNT162B2 vaccination |
Ravin Hettiarachchi, Kartik Naidu, Suzanne Payne, Juliette Holland |
| 30 |
[GO] |
2022―Feb―03 |
False positive results seen at high CT values with the Xpert Xpress SARS-CoV-2 test |
Shireen Y.L. Tan, Sui Sin Goh, Kenneth X.L. Chan, James H.C. Sim, Karrie K.K. Ko |
| 31 |
[GO] |
2022―Feb―03 |
A case of prolonged SARS-CoV-2 viral shedding for 150 days |
Andrew Fox-Lewis, Shivani Fox-Lewis, Sandra Hotu, Sally Roberts, Gary McAuliffe, Mary De Almeida |
| 32 |
[GO] |
2022―Feb―03 |
Rapid antigen tests for positive Covid-19 confirmation in the laboratory setting |
Mikaela Dewar, Anica Pjevalica, Nicholas Clay, Brock Reitzer-Parks, Caitlin L. Keighley |
| 33 |
[GO] |
2022―Feb―03 |
Management of deaths in temporal relationship to COVID-19 immunisation in NSW |
Isabel Brouwer, Dianna Inmon, Angela Duncan |
| 34 |
[GO] |
2022―Feb―03 |
An update on Covid-19 serology |
Paul M. Kinsella, Theo Karapanagiotidis, Suellen Nicholson, Deborah A. Williamson |
| 35 |
[GO] |
2022―Feb―03 |
Investigation of deaths following COVID-19 vaccination in Western Australia |
Kirralee Patton, Leana Downs, Clive Cooke, Jodi White, Victoria Kueppers |
| 36 |
[GO] |
2022―Feb―03 |
Discordant SARS-CoV-2 RNA results obtained using the Roche cobas liat SARS-CoV-2 |
Gayle Warnock, Peter Newton |
| 37 |
[GO] |
2022―Feb―03 |
Severe terminal ileitis following SARS-CoV-2 infection: A histopathological case report |
Brett Fivelman, Angela Harris |
| 38 |
[GO] |
2022―Feb―03 |
Airborne transmission of SARS-CoV-2 lineage B.1.617.2 (Delta variant) within a tightly monitored isolation facility |
Andrew Fox-Lewis, Felicity Williamson, Jay Harrower, Xiaoyun Ren, Gerard J.B. Sonder, Andrea McNeill, Joep de Ligt, Jemma L. Geoghegan |
| 39 |
[GO] |
2022―Feb―03 |
De novo design of CRISPR-Cas13b enables efficient silencing of SARS-CoV-2 variants and tumour pathogenic RNAs with near single-base precision |
Wenxin Hu, Wei Zhao, Amit Kumar, Gurjeet Jagjeet Singh, Shijiao Qi, Josh Casan, Carolyn Shembery, Danielle Fong, Jennifer M. Zerbato, Jori Symons, Rajeev Rudraraju, Damian Purcell, Michelle Haber, Ilia Voskoboinik, Paul G. Ekert, Sharon Lewin, Joseph Trapani, Mohamed Fareh |
| 40 |
[GO] |
2022―Feb―03 |
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: A multicentre cross-sectional observational study |
Andrew Fox-Lewis, Shivani Fox-Lewis, Jenna Beaumont, Dragana Drinković, Jay Harrower, Kevin Howe, Catherine Jackson, Fahimeh Rahnama, Blair Shilton, Helen Qiao, Kevin K. Smith, Susan C. Morpeth, Susan Taylor, Matthew Blakiston, Sally Roberts, Gary McAuliffe |
| 41 |
[GO] |
2022―Feb―03 |
An unusual case of heparin-induced thrombocytopenia in a patient infected with SARS-CoV-2 virus |
Jian Li |
| 42 |
[GO] |
2022―Feb―03 |
Verification and implementation of a rapid antigen test for SARS-CoV2 detection in clinical settings in Sydney local health district (SLHD) |
Susy Mathew, John Saunders, Jacquelyn Petty, Rebecca Davis |
| 43 |
[GO] |
2022―Feb―02 |
Validation of specimen pooling using the Cepheid Xpert Xpress SARS-CoV-2 assay |
Rifky Balgahom, Vishal Ahuja, Catherine Pitman, Adam Polkinghorne, James Branley |
| 44 |
[GO] |
2022―Jan―31 |
Rapid detection of the widely circulating B.1.617.2 (Delta) SARS-CoV-2 variant |
Adriana E. Rosato, Engy Msiha, Bruce Weng, Michael Mesisca, Ronaldo Gnass, Silvia Gnass, Cedric Bol, Arnold Tabuenca, Roberto R. Rosato |
| 45 |
[GO] |
2021―Nov―23 |
Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting |
Hemalatha Varadhan, Vishal Ahuja, Catherine Pitman, Dominic E. Dwyer |
| 46 |
[GO] |
2021―Nov―08 |
Cytotoxic CD8 positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis |
Andrii Puzyrenko, Juan C. Felix, Nathan A. Ledeboer, Yunguang Sun, Hallgeir Rui, Yuri Sheinin |
| 47 |
[GO] |
2021―Nov―06 |
Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection |
Riham Abdel-Hamid Haroun, Waleed H. Osman, Rasha E. Amin, Ahmad K. Hassan, Walefed S. Abo-Shanab, Asmaa M. Eessa |
| 48 |
[GO] |
2021―Oct―22 |
Analytical sensitivity and specificity of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV assay |
Nicole Isles, Steven G. Badman, Susan Ballard, Bowen Zhang, Benjamin P. Howden, Rebecca Guy, Deborah A. Williamson |
| 49 |
[GO] |
2021―Sep―23 |
Prolonged PCR positivity in elderly patients infected with SARS-CoV-2 |
Annaleise R. Howard-Jones, Susan Maddocks, Kerri Basile, Dominic E. Dwyer, James Branley, Jen Kok |
| 50 |
[GO] |
2021―Sep―23 |
SARS-CoV-2-specific IgM screening has low sensitivity for identifying potentially infectious travellers |
Tasnim Hasan, Hui Lim, Linda Hueston, Dominic E. Dwyer, Matthew O’Sullivan |
| 51 |
[GO] |
2021―Sep―04 |
Multi-site point of care assessment of Abbott ID NOW rapid molecular test for SARS-CoV-2 in a low-prevalence setting |
Maryza Graham, Stephen Muhi, Tuyet Hoang, Susan A. Ballard, Julie McAuley, Jason C. Kwong, Deborah A. Williamson, Benjamin P. Howden |
| 52 |
[GO] |
2021―Aug―10 |
Use of emerging testing technologies and approaches for SARS-CoV-2: review of literature and global experience for the Australian context |
Maryza Graham, Susan A. Ballard, Shivani Pasricha, Belinda Lin, Tuyet Hoang, Timothy Stinear, Julian Druce, Mike Catton, Norelle Sherry, Deborah Williamson, Benjamin P. Howden |
| 53 |
[GO] |
2021―Jul―20 |
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection |
K.A. Bond, E. Williams, S. Nicholson, S. Lim, D. Johnson, B. Cox, M. Putland, E. Gardiner, E. Tippett, M. Graham, F. Mordant, M. Catton, S.R. Lewin, K. Subbarao, B.P. Howden, D.A. Williamson |
| 54 |
[GO] |
2021―Jun―24 |
Coronial cases: SARS-CoV-2 infection and Covid-19 |
Linda Iles |
| 55 |
[GO] |
2021―Jun―24 |
Coronial cases: SARS-CoV-2 infection and covid-19 |
Linda Iles |
| 56 |
[GO] |
2021―Jun―24 |
Coronial cases: SARS-CoV-2 infection and covid-19 |
Linda Iles |
| 57 |
[GO] |
2021―Jun―24 |
Clinical forensic medicine and Covid-19 challenges: the melbourne experience |
Janine Rowse, Nicola Cunningham, Jo Ann Parkin |
| 58 |
[GO] |
2021―Jun―24 |
Patient blood management - a review of accepted practice; with a focus on optimising patient outcomes during the current COVID-19 pandemic |
Bryony Ross, Lisa Clarke, Peter Freeman |
| 59 |
[GO] |
2021―Jun―24 |
COVID-19: 2020 VISION |
Mike Catton |
| 60 |
[GO] |
2021―Jun―24 |
Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and covid19 |
William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, Mariana Ruiz da Silva, Charles Foster |
| 61 |
[GO] |
2021―Jun―24 |
Background, testing methods, and laboratory approaches to SARS coronavirus-2 (SARS-CoV-2) and Covid19 |
William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, Mariana Ruiz da Silva, Charles Foster |
| 62 |
[GO] |
2021―Jun―24 |
Background, testing methods, and laboratory approaches to sars coronavirus-2 (SARS-CoV-2) and covid19 |
William D. Rawlinson, Sebastiaan van Hal, Malinna Yeang, Anna Condylios, Zin Naing, Jane-Phan Au, Mariana Ruiz da Silva, Charles Foster |
| 63 |
[GO] |
2021―Jun―24 |
Comparative evaluation and longevity of neutralising and binding antibodies for SARS-COV-2 |
Natalie Davidson, Jenny Evans, Jenny Robson |
| 64 |
[GO] |
2021―Jun―24 |
Expression of GPI-anchored SARS-CoV-2 receptor binding domain in mammalian cells for serological use |
M.L. Kernich, P.J. Adamson, J.J. Wang, L.P. Kris, B.L. Armour, D. Beroukas, G. Best, J.M. Carr, T.P. Gordon, D.L. Gordon |
| 65 |
[GO] |
2021―May―18 |
SARS-CoV-2 antibodies in the Southern Region of New Zealand, 2020 |
Alyson Craigie, Reuben McGregor, Alana L. Whitcombe, Lauren Carlton, David Harte, Michelle Sutherland, Matthew Parry, Erasmus Smit, Gary McAuliffe, James Ussher, Nicole J. Moreland, Susan Jack, Arlo Upton |
| 66 |
[GO] |
2021―Mar―20 |
SARS-CoV-2 viral load dynamics and real-time RT-PCR cycle threshold interpretation in symptomatic non-hospitalised individuals in New Zealand: a multicentre cross sectional observational study |
Andrew Fox-Lewis, Shivani Fox-Lewis, Jenna Beaumont, Dragana Drinković, Jay Harrower, Kevin Howe, Catherine Jackson, Fahimeh Rahnama, Blair Shilton, Helen Qiao, Kevin K. Smith, Susan C. Morpeth, Susan Taylor, Matthew Blakiston, Sally Roberts, Gary McAuliffe |
| 67 |
[GO] |
2020―Oct―08 |
Focus on SARS-CoV-2 and COVID-19 |
Sharon C-A Chen, William D. Rawlinson |
| 68 |
[GO] |
2020―Oct―08 |
Laboratory diagnosis of severe acute respiratory syndrome coronavirus 2 |
T. Gulholm, K. Basile, J. Kok, S.C.-A. Chen, W. Rawlinson |
| 69 |
[GO] |
2020―Oct―08 |
Virus isolation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for diagnostic and research purposes |
Gregory Walker, Anupriya Aggarwal, Sonia Underwood, Malinna Yeang, Zin Naing, Alberto Ospina Stella, Stuart Turville, William Rawlinson |
| 70 |
[GO] |
2020―Oct―05 |
The impact of viral transport media on PCR assay results for the detection of nucleic acid from SARS-CoV-2 |
P.D. Kirkland, M.J. Frost |
| 71 |
[GO] |
2020―Sep―30 |
Accuracy amidst ambiguity: false positive SARS-CoV-2 nucleic acid tests when COVID-19 prevalence is low |
K. Basile, S. Maddocks, J. Kok, D.E. Dwyer |
| 72 |
[GO] |
2020―Sep―30 |
Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent |
Alexa M. Kaufer, Torsten Theis, Katherine A. Lau, Joanna L. Gray, William D. Rawlinson |
| 73 |
[GO] |
2020―Sep―30 |
Comparative analysis of three laboratory based serological assays for SARS-CoV-2 in an Australian cohort |
N. Davidson, J. Evans, D. Giammichele, H. Powell, P. Hobson, B. Teis, H. Glover, K.B. Guppy-Coles, J. Robson |
| 74 |
[GO] |
2020―Sep―30 |
Head-to-head evaluation on diagnostic accuracies of six SARS-CoV-2 serological assays |
Shaun S. Tan, Sharon Saw, Ka Lip Chew, Chan Yiong Huak, Candy Khoo, Anastacia Pajarillaga, Weixuan Wang, Paul Tambyah, Lizhen Ong, Roland Jureen, Sunil K. Sethi |
| 75 |
[GO] |
2020―Sep―29 |
Is prostate infarction and acute urinary retention a possible complication of severe COVID-19 infection? |
Sergio A.C. Duarte, Jessica G. Pereira, Alexandre Iscaife, Katia R.M. Leite, Alberto A. Antunes |
| 76 |
[GO] |
2020―Sep―22 |
Sample pooling is a viable strategy for SARS-CoV-2 detection in low-prevalence settings |
Brian S.W. Chong, Thomas Tran, Julian Druce, Susan A. Ballard, Julie A. Simpson, Mike Catton |
| 77 |
[GO] |
2020―Sep―22 |
Clinical evaluation of SARS-CoV-2 point-of-care tests |
Roselle s. Robosa, Indy Sandaradura, Dominic e. Dwyer, Matthew v.N. O’sullivan |
| 78 |
[GO] |
2020―Sep―21 |
Clinical evaluation of four commercial immunoassays for the detection of antibodies against established SARS-CoV-2 infection |
Kyra Y.L. Chua, Sara Vogrin, Intissar Bittar, Jennifer H. Horvath, Hari Wimaleswaran, Jason A. Trubiano, Natasha E. Holmes, Que Lam |
| 79 |
[GO] |
2020―Sep―01 |
Implementation and evaluation of a novel real-time multiplex assay for SARS-CoV-2: in-field learnings from a clinical microbiology laboratory |
Eloise Williams, Katherine Bond, Brian Chong, Dawn Giltrap, Malcolm Eaton, Peter Kyriakou, Peter Calvert, Bowen Zhang, Mahendra Siwan, Benjamin Howden, Julian Druce, Mike Catton, Deborah A. Williamson |
| 80 |
[GO] |
2020―Aug―19 |
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings |
Phoebe C.M. Williams, Annaleise R. Howard-Jones, Peter Hsu, Pamela Palasanthiran, Paul E. Gray, Brendan J. McMullan, Philip N. Britton, Adam W. Bartlett |
| 81 |
[GO] |
2020―Aug―19 |
Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer |
Claire Y.T. Wang, Cameron Buckley, Cheryl Bletchly, Patrick Harris, David Whiley |
| 82 |
[GO] |
2020―Aug―12 |
Histopathology of cutaneous COVID-19 lesion: possible SARS-CoV-2 cytopathogenic effect |
Kinan Drak Alsibai, Celine Michaud, Alex Taquet, Magalie Demar, Romain Blaizot |
| 83 |
[GO] |
2020―Jul―10 |
Rapid deployment of pathology services to a remote Australian quarantine setting during the COVID-19 pandemic |
James Branley, Matthew O’Sullivan, Adam Polkinghorne, Marin Poljak, Dianne Stephens |
